aTyr Pharma to present efzofitimod subgroup data at WASOG 2026

July 15, 2026 8:00 AM

aTyr Pharma, Inc. (Nasdaq: ATYR) announced it will present a subgroup analysis of its Phase 3 EFZO-FIT™ study of efzofitimod ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found